About: NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Sector: Healthcare
Industry: Medical Devices
Latest price: $14.39 (-2.24%)
NVCR NASDAQ Novocure Ltd
Novocure Ltd share price
NVCR price activity
Last Price
$14.390
Change (24hr)
-0.33 USD (-2.24%)
Volume
238.96K
Volume (4w avg)
-
Open
$14.66
Day Range
$14.39 - $14.66
Previous Close
$14.72
Last Trade
13 Oct, 5:34 pm GMT+0
Delayed
13 Oct, 5:34 pm GMT+0
NVCR price performance
Delayed
13 Oct, 5:34 pm GMT+0
NVCR Market Signals